NanoViricides Inc. (NNVC)

[drkazmd65]

As I have stated when you make statements like this previous JG,... you are quite right in most of what you state.

The biggest point I differ from you is in that I don't think that a partial success (as I do not think that either the previous version of Ebolacide was an abject failure,.... except in not producing a revenue source) for Ebolacide v2 will have as negative an effect on shareprices here as do you.

That is to say that since the Ebolacide direction is (apparently) viewed as a longshot by the market and many potential investors anyway - a not completely satisfactory positive result is already kind of factored into the current shareprices.

I also continue to disagree with this statement:

The first version of Ebolacide didn't cure any mice. Now they say we understand the virus better, and know the right receptor to use. Well, maybe. Or maybe there's more about the Ebola virus that we still don't know.

The treated mice in the previous experiments did have an positive reaction to the drug candidates,... they lived a statistically longer time than did their control mice. Even the unsatisfactory lab result wasn't a total failure. It just wasn't enough to keep the funding agencies interested at the time,.... when there was no significant (c2010) Ebola problem to be addressed.

So I would argue that it is a gamble,.... but not a high-risk gamble in going for the Ebola target.

Others,... obviously,.... disagree. And for them a different investment strategy is where they should look.

And I can state for myself - that IF (and I don't view this as likely) shareprices drop down into a range under $2/share,.... I will be looking to add shares and continue to play the 'long-game'.